Gilead Takes Key FCA Battle To Supreme Court
By Jeff Overley · January 4, 2018, 10:16 PM EST
Gilead Sciences is urging the U.S. Supreme Court to review a Ninth Circuit decision that let a False Claims Act suit proceed even though regulators didn't halt drug reimbursement after learning...
To view the full article, register now.